DRUG:
JCAR018
i
Other names: JCAR018, anti-CD22 chimeric antigen receptor T-cells, T-cell chimeric antigen receptor cellular therapy targeting CD-22, CD22-CAR, JCAR-018, JCAR 018, anti-CD22-human scFv CAR T cell therapy
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners